Literature DB >> 9769321

A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy.

Q Yang1, A Sanbe, H Osinska, T E Hewett, R Klevitsky, J Robbins.   

Abstract

Familial hypertrophic cardiomyopathy can be caused by mutations in genes encoding sarcomeric proteins, including the cardiac isoform of myosin binding protein C (MyBP-C), and multiple mutations which cause truncated forms of the protein to be made are linked to the disease. We have created transgenic mice in which varying amounts of a mutated MyBP-C, lacking the myosin and titin binding domains, are expressed in the heart. The transgenically encoded, truncated protein is stable but is not incorporated efficiently into the sarcomere. The transgenic muscle fibers showed a leftward shift in the pCa2+-force curve and, importantly, their power output was reduced. Additionally, expression of the mutant protein leads to decreased levels of endogenous MyBP-C, resulting in a striking pattern of sarcomere disorganization and dysgenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9769321      PMCID: PMC508976          DOI: 10.1172/JCI3880

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart.

Authors:  W A Ng; I L Grupp; A Subramaniam; J Robbins
Journal:  Circ Res       Date:  1991-06       Impact factor: 17.367

2.  Troponin T expression in normal and pressure-loaded fetal sheep heart.

Authors:  J J McAuliffe; J Robbins
Journal:  Pediatr Res       Date:  1991-06       Impact factor: 3.756

3.  A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.

Authors:  A A Geisterfer-Lowrance; S Kass; G Tanigawa; H P Vosberg; W McKenna; C E Seidman; J G Seidman
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

4.  Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.

Authors:  H Niimura; L L Bachinski; S Sangwatanaroj; H Watkins; A E Chudley; W McKenna; A Kristinsson; R Roberts; M Sole; B J Maron; J G Seidman; C E Seidman
Journal:  N Engl J Med       Date:  1998-04-30       Impact factor: 91.245

5.  Effects on shortening velocity of rabbit skeletal muscle due to variations in the level of thin-filament activation.

Authors:  R L Moss
Journal:  J Physiol       Date:  1986-08       Impact factor: 5.182

6.  A new protein of the thick filaments of vertebrate skeletal myofibrils. Extractions, purification and characterization.

Authors:  G Offer; C Moos; R Starr
Journal:  J Mol Biol       Date:  1973-03-15       Impact factor: 5.469

7.  Identification of a new missense mutation in MyBP-C associated with hypertrophic cardiomyopathy.

Authors:  J C Moolman-Smook; B Mayosi; P Brink; V A Corfield
Journal:  J Med Genet       Date:  1998-03       Impact factor: 6.318

8.  The velocity of unloaded shortening and its relation to sarcomere length and isometric force in vertebrate muscle fibres.

Authors:  K A Edman
Journal:  J Physiol       Date:  1979-06       Impact factor: 5.182

9.  Determinants of loaded shortening velocity in single cardiac myocytes permeabilized with alpha-hemolysin.

Authors:  N K Sweitzer; R L Moss
Journal:  Circ Res       Date:  1993-12       Impact factor: 17.367

10.  The major myosin-binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH-terminal, immunoglobulin C2 motif.

Authors:  T Okagaki; F E Weber; D A Fischman; K T Vaughan; T Mikawa; F C Reinach
Journal:  J Cell Biol       Date:  1993-11       Impact factor: 10.539

View more
  57 in total

Review 1.  Molecular genetics of cardiomyopathies.

Authors:  G Shah; R Roberts
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

Review 2.  Meeting Koch's postulates for calcium signaling in cardiac hypertrophy.

Authors:  K R Chien
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 3.  The molecular genetic basis for hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

4.  Functional characterization of the human α-cardiac actin mutations Y166C and M305L involved in hypertrophic cardiomyopathy.

Authors:  Mirco Müller; Antonina Joanna Mazur; Elmar Behrmann; Ralph P Diensthuber; Michael B Radke; Zheng Qu; Christoph Littwitz; Stefan Raunser; Cora-Ann Schoenenberger; Dietmar J Manstein; Hans Georg Mannherz
Journal:  Cell Mol Life Sci       Date:  2012-05-29       Impact factor: 9.261

Review 5.  The genetic basis of hypertrophic cardiomyopathy in cats and humans.

Authors:  Mark D Kittleson; Kathryn M Meurs; Samantha P Harris
Journal:  J Vet Cardiol       Date:  2015-12       Impact factor: 1.701

Review 6.  MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutation.

Authors:  Diederik W D Kuster; Sakthivel Sadayappan
Journal:  Pflugers Arch       Date:  2013-12-11       Impact factor: 3.657

7.  Cardiac myosin binding protein C phosphorylation is cardioprotective.

Authors:  Sakthivel Sadayappan; Hanna Osinska; Raisa Klevitsky; John N Lorenz; Michelle Sargent; Jeffrey D Molkentin; Christine E Seidman; Jonathan G Seidman; Jeffrey Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

8.  Disruption of myofibrillar proteins in cardiac muscle of Calomys callosus chronically infected with Trypanosoma cruzi and treated with immunosuppressive agent.

Authors:  Noemi N Taniwaki; Walter K Andreoli; Kátia S Calabrese; Solange da Silva; Renato A Mortara
Journal:  Parasitol Res       Date:  2005-08-02       Impact factor: 2.289

Review 9.  Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathy.

Authors:  Amelia A Glazier; Andrea Thompson; Sharlene M Day
Journal:  Pflugers Arch       Date:  2018-11-20       Impact factor: 3.657

10.  In vivo definition of cardiac myosin-binding protein C's critical interactions with myosin.

Authors:  Md Shenuarin Bhuiyan; Patrick McLendon; Jeanne James; Hanna Osinska; James Gulick; Bidur Bhandary; John N Lorenz; Jeffrey Robbins
Journal:  Pflugers Arch       Date:  2016-08-27       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.